The Incidence of and Factors Associated with Vitamin D Deficiency in Newly Diagnosed Children with Cancer

References

• Saggese G, Vierucci F, Boot AM, Czech-Kowalska J, Weber G, et al.: Vitamin D in childhood and adolescence: an expert position statement. Eur J Pediatr 174(5), 565–576, 2015.
   PubMed Web of Science ®Google Scholar
• Musselman JR and Spector LG: Childhood cancer incidence in relation to sunlight exposure. Br J Cancer 104, 214–220, 2011.
   PubMed Web of Science ®Google Scholar
• Petridou ET, Dikalioti SK, Skalkidou A, Andrie E, Dessypris N, et al.: Sun exposure, birth weight, and childhood lymphomas: a case control study in Greece. Cancer Causes Control 18, 1031–1037, 2007.
   PubMed Web of Science ®Google Scholar
• Uhmann A, Niemann H, Lammering B, Henkel C, Hess I, et al.: Calcitriol inhibits hedgehog signaling and induces vitamin d receptor signaling and differentiation in the patched mouse model of embryonal rhabdomyosarcoma. Sarcoma 16, 357040, 2012.
   Google Scholar
• Maurer U, Jehan F, Englert C, Hubinger G, Weidmann E, et al.: The Wilms' tumor gene product (WT1) modulates the response to 1,25-dihydroxyvitamin D3 by induction of the vitamin D receptor. J Biol Chem 276, 3727–3732, 2001.
   PubMed Web of Science ®Google Scholar
• Lange TS, Singh RK, Kim KK, Zou Y, Kalkunte SS, et al.: Anti-proliferative and pro-apoptotic properties of 3-bromoacetoxy calcidiol in high-risk neuroblastoma. Chem Biol Drug Des 70, 302–310, 2007.
   PubMed Web of Science ®Google Scholar
• Arikoski P, Komulainen J, Riikonen P, Voutilainen R, Knip M, et al.: Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study. J Clin Endocrinol Metab 84, 3174–3181, 1999.
   PubMed Web of Science ®Google Scholar
• Atkinson SA, Halton JM, Bradley C, Wu B, and Barr RD: Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition. Int J Cancer Suppl 11, 35–39, 1998.
   PubMedGoogle Scholar
• Boot A, van den Heuvel-Eibrink MM, Hahlen K, Krenning EP, and de Muick Keizer-Schrama SMPF: Bone mineral density in children with acute lymphoblastic leukemia. Eur J Cancer 35, 1693–1697, 1999.
   PubMed Web of Science ®Google Scholar
• Choudhary A, Chou J, Heller G, and Sklar C: Prevalence of vitamin D insufficiency in survivors of childhood cancer. Pediatr Blood Cancer 60, 1237–1239, 2013.
   PubMed Web of Science ®Google Scholar
• El-Ziny MA, Al-Tonbary YA, Salama OS, Bakr A, Al-Marsafawy H, et al.: Low bone mass in children with malignant lymphoma. Pediatr Hematol Oncol 24, 577–585, 2007.
   PubMed Web of Science ®Google Scholar
• El-Ziny MA, Al-Tonbary YA, Salama OS, Bakr AA, Al-Marsafawy H, et al.: Low turnover bone disease in Egyptian children with acute leukemia. Hematology 10, 327–333, 2005.
   PubMed Web of Science ®Google Scholar
• Halton JM, Atkinson SA, Fraher L, Webber C, Gill GJ, et al.: Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res 11, 1774–1783, 1996.
   PubMed Web of Science ®Google Scholar
• Halton JM, Atkinson SA, Fraher L, Webber CE, Cockshott WP, et al.: Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia. J Pediatr 126, 557–564, 1995.
   PubMed Web of Science ®Google Scholar
• van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, Krenning EP, and de Muinck Keizer-Schrama SM: Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. J Pediatr 141, 204–210, 2002.
   PubMed Web of Science ®Google Scholar
• Revuelta Iniesta R, Rush R, Paciarotti I, Rhatigan EB, Brougham FH, et al.: Systematic review and meta-analysis: Prevalence and possible causes of vitamin D deficiency and insufficiency in pediatric cancer patients. Clin Nutr 35, 1, 95–108, 2015.
   PubMed Web of Science ®Google Scholar
• Holick MF: Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets 12, 4–18, 2011.
   PubMed Web of Science ®Google Scholar
• Arikoski P, Komulainen J, Riikonen P, Parviainen M, Jurvelin JS, et al.: Impaired development of bone mineral density during chemotherapy: a prospective analysis of 46 children newly diagnosed with cancer. J Bone Miner Res 14, 2002–2009, 1999.
   PubMed Web of Science ®Google Scholar
• Wilson CL and Ness KK: Bone mineral density deficits and fractures in survivors of childhood cancer. Curr Osteoporos Rep 11, 329–337, 2013.
   PubMed Web of Science ®Google Scholar
• http://www.survivorshipguidelines.org/pdf/LTFUGuidelines_40.pdf.
   Google Scholar
• Bundak R, Furman A, Gunoz H, Darendeliler F, Bas F, et al.: Body mass index references for Turkish children. Acta Paediatr 95, 194–198, 2006.
   PubMed Web of Science ®Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al.: Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96, 1911–1930, 2011.
   PubMed Web of Science ®Google Scholar
• Henderson RC, Madsen CD, Davis C, and Gold SH: Longitudinal evaluation of bone mineral density in children receiving chemotherapy. J Pediatr Hematol Oncol 20, 322–326, 1998.
   PubMed Web of Science ®Google Scholar
• Helou M, Ning Y, Yang S, Irvine P, Bachmann LM, et al.: Vitamin d deficiency in children with cancer. J Pediatr Hematol Oncol 36, 212–217, 2014.
   PubMed Web of Science ®Google Scholar
• Akman AO, Tumer L, Hasanoglu A, Ilhan M, and Cayci B: Frequency of vitamin D insufficiency in healthy children between 1 and 16 years of age in Turkey. Pediatr Int 53, 968–973, 2011.
   PubMed Web of Science ®Google Scholar
• Hatun S, Islam O, Cizmecioglu F, Kara B, Babaoglu K, et al.: Subclinical vitamin D deficiency is increased in adolescent girls who wear concealing clothing. J Nutr 135, 218–222, 2005.
   PubMed Web of Science ®Google Scholar
• Webb AR, Kline L, and Holick MF: Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67, 373–378, 1988.
   PubMed Web of Science ®Google Scholar
• Vashi PG, Lammersfeld CA, Braun DP, and Gupta D: Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer. Nutr J 10, 51, 2011.
   PubMed Web of Science ®Google Scholar
• DA F: Drug Interactions: Cytochrome P450 Drug Interaction Table. Indiana University School of Medicine, “/clinpharm/ddis/clinical-table/”, 2007.
   Google Scholar
• Ahn JH, Cho WH, Lee JA, Kim DH, Seo JH, et al.: Bone mineral density change during adjuvant chemotherapy in pediatric osteosarcoma. Ann Pediatr Endocrinol Metab 20, 150–154, 2015.
   PubMedGoogle Scholar
• Wang Z, Schuetz EG, Xu Y, and Thummel KE: Interplay between vitamin D and the drug metabolizing enzyme CYP3A4. J Steroid Biochem Mol Biol 136, 54–58, 2013.
   PubMed Web of Science ®Google Scholar
• Rocha V, Porcher R, Fernandes JF, Filion A, Bittencourt H, et al.: Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia. Leukemia 23(3), 545–556, 2009.
   PubMed Web of Science ®Google Scholar
• Bienertova-Vasku J, Drabova K, Zlamal F, Tomandl J, Kyr M, et al.: Pre-treatment VD levels and VDR receptors as potential predictors of occurrence and overall survival in paediatric patients with solid tumours-a single institution pilot study. Tumour Biol [Epub ahead of print], 2016. doi:10.1007/s13277-016-4820-9
   PubMed Web of Science ®Google Scholar